$1.24 EPS Expected for Unum Group (UNM); Merck & Co (MRK) Sentiment Is 0.93

April 24, 2018 - By Maria Brooks

Unum Group (NYSE:UNM) Logo

Merck & Co Inc (MRK) investors sentiment decreased to 0.93 in 2017 Q4. It’s down -0.12, from 1.05 in 2017Q3. The ratio has worsened, as 688 institutional investors increased or started new stock positions, while 736 sold and reduced their positions in Merck & Co Inc. The institutional investors in our database now have: 1.92 billion shares, down from 1.95 billion shares in 2017Q3. Also, the number of institutional investors holding Merck & Co Inc in top ten stock positions decreased from 84 to 46 for a decrease of 38. Sold All: 93 Reduced: 643 Increased: 566 New Position: 122.

Analysts expect Unum Group (NYSE:UNM) to report $1.24 EPS on May, 1 after the close.They anticipate $0.22 EPS change or 21.57% from last quarter’s $1.02 EPS. UNM’s profit would be $274.25M giving it 9.84 P/E if the $1.24 EPS is correct. After having $1.13 EPS previously, Unum Group’s analysts see 9.73% EPS growth. The stock decreased 0.18% or $0.09 during the last trading session, reaching $48.79. About 708,725 shares traded. Unum Group (NYSE:UNM) has risen 4.49% since April 24, 2017 and is uptrending. It has underperformed by 7.06% the S&P500.

Since December 14, 2017, it had 0 insider purchases, and 6 selling transactions for $1.52 million activity. Arnold Timothy Gerald sold $55,070 worth of stock or 1,000 shares. Another trade for 8,459 shares valued at $463,807 was made by IGLESIAS LISA G on Thursday, December 14. Waxenberg Daniel Jason also sold $75,134 worth of Unum Group (NYSE:UNM) on Friday, February 23. 5,000 shares were sold by Simonds Michael Q, worth $260,450 on Monday, February 5. The insider Jerome Christopher J sold 7,806 shares worth $397,325. 4,588 shares were sold by McGarry John F, worth $266,976.

Investors sentiment increased to 1.06 in 2017 Q4. Its up 0.21, from 0.85 in 2017Q3. It is positive, as 16 investors sold Unum Group shares while 169 reduced holdings. 64 funds opened positions while 133 raised stakes. 197.64 million shares or 1.55% less from 200.74 million shares in 2017Q3 were reported. Moreover, Mckinley Management Limited Company Delaware has 0% invested in Unum Group (NYSE:UNM). Profund Lc stated it has 6,883 shares or 0.01% of all its holdings. Guardian Life Insur Comm Of America stated it has 0.01% of its portfolio in Unum Group (NYSE:UNM). Sumitomo Mitsui Asset Management, Japan-based fund reported 15,680 shares. Twin Cap accumulated 30,210 shares. Art Advisors Lc owns 33,100 shares. Bnp Paribas Arbitrage Sa holds 135,060 shares. Adage Partners Group Ltd Liability Corporation owns 318,069 shares or 0.04% of their US portfolio. Grace White invested in 5.97% or 540,970 shares. Coastline Tru Communications holds 0.04% or 4,300 shares in its portfolio. Engineers Gate Manager L P accumulated 55,282 shares. Meritage Port Management owns 109,030 shares for 0.57% of their portfolio. Spinnaker Trust holds 0.04% or 6,019 shares in its portfolio. Tower Limited Liability Corp (Trc) owns 1,549 shares or 0.01% of their US portfolio. Fuller Thaler Asset Mngmt reported 0% of its portfolio in Unum Group (NYSE:UNM).

Unum Group, together with its subsidiaries, provides group and individual disability insurance services and products primarily in the United States and the United Kingdom. The company has market cap of $10.79 billion. It operates through Unum US, Unum UK, Colonial Life, and Closed Block divisions. It has a 11.16 P/E ratio. The firm offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.

Among 16 analysts covering Unum Group (NYSE:UNM), 6 have Buy rating, 2 Sell and 8 Hold. Therefore 38% are positive. Unum Group had 44 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was downgraded by Bank of America to “Underperform” on Wednesday, June 29. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Friday, November 10. RBC Capital Markets maintained the stock with “Outperform” rating in Thursday, July 30 report. The company was initiated on Friday, October 7 by Credit Suisse. The rating was upgraded by FBR Capital on Monday, November 6 to “Hold”. RBC Capital Markets maintained Unum Group (NYSE:UNM) on Thursday, April 28 with “Outperform” rating. The stock of Unum Group (NYSE:UNM) earned “Hold” rating by Keefe Bruyette & Woods on Thursday, December 21. SunTrust maintained Unum Group (NYSE:UNM) on Thursday, April 12 with “Buy” rating. The stock of Unum Group (NYSE:UNM) earned “Neutral” rating by Bank of America on Thursday, December 3. The stock of Unum Group (NYSE:UNM) has “Buy” rating given on Monday, February 12 by FBR Capital.

The stock increased 2.41% or $1.42 during the last trading session, reaching $60.25. About 19.82M shares traded or 55.13% up from the average. Merck & Co., Inc. (MRK) has declined 14.94% since April 24, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1 before the open. They expect $0.99 earnings per share, up 12.50% or $0.11 from last year’s $0.88 per share. MRK’s profit will be $2.67 billion for 15.21 P/E if the $0.99 EPS becomes a reality. After $0.98 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 1.02% EPS growth.

Ratings analysis reveals 86% of Merck’s analysts are positive. Out of 7 Wall Street analysts rating Merck, 6 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. MRK was included in 7 notes of analysts from September 9, 2016. Bank of America upgraded the stock to “Buy” rating in Thursday, October 13 report. The firm has “Buy” rating by Guggenheim given on Thursday, January 12. Barclays Capital maintained the shares of MRK in report on Friday, September 9 with “Overweight” rating. Morgan Stanley upgraded Merck & Co., Inc. (NYSE:MRK) on Thursday, January 12 to “Overweight” rating. The firm has “Underperform” rating given on Monday, December 19 by Jefferies. Bryan Garnier & Cie initiated the stock with “Buy” rating in Friday, January 13 report. The firm has “Overweight” rating by Piper Jaffray given on Thursday, January 12.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: